Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRA... by Grob, Jean Jacques, Prof, Amonkar, Mayur M, PhD, Karaszewska, Boguslawa, MD, Schachter, Jacob, Prof, Dummer, Reinhard, Prof, Mackiewicz, Andrzej, Prof, Stroyakovskiy, Daniil, MD, Drucis, Kamil, MD, Grange, Florent, MD, Chiarion-Sileni, Vanna, MD, Rutkowski, Piotr, Prof, Lichinitser, Mikhail, Prof, Levchenko, Evgeny, MD, Wolter, Pascal, MD, Hauschild, Axel, Prof, Long, Georgina V, MD, Nathan, Paul, MD, Ribas, Antoni, Prof, Flaherty, Keith, MD, Sun, Peng, PhD, Legos, Jeffrey J, PhD, McDowell, Diane Opatt, MD, Mookerjee, Bijoyesh, MD, Schadendorf, Dirk, Prof, Robert, Caroline, MD

Get full text

Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients by Smith, John W., Vukelja, Svetislava, Rabe, Amy, Wentworth-Hartung, Nicole, Koutrelakos, Nicholas, Shao, Spencer H., Whittaker, Thomas, Wang, Yunfei, Asmar, Lina, McDowell, Diane Opatt, Mukhopadhyay, Pralay, O’Shaughnessy, Joyce

Get full text